<p>Chemical structures of compounds with ε-Pol inhibitory activity (A), and without ε-Pol inhibitory activity (B).</p
<p>Chemical structure of the drugs with TRPM8 antagonist activity used in this study.</p
<p>Molecular structures of NVS-PI3-2 (α inhibitor), HBC-417 (β inhibitor), NVS-PI3-3 (δ inhibitor) a...
<p>Chemical structure of the nicotinamide phosphoribosyltransferase inhibitor APO866.</p
<p>Chemical structure of screened inhibitors (A) ZINC01807204 (B) ZIC02318494.</p
<p>Chemical structures of the 6 hit compounds exhibiting anti-CHIKV activities.</p
<p>Chemical structures of the studied non-nucleoside reverse transcriptase inhibitors.</p
<p>Structures of compounds that are structurally related to the nine compounds identified in our vir...
<p>Chemical structures of fluorescein-di-β-d-galactopyranoside (FDG), fluorescein, and inhibitors.</...
<p>Molecular structures of the inhibitors: (A) PMI, (B) pDI, (C) WK23 and (D) WW8.</p
Chemical structures of Qi inhibitors (left), Qo inhibitors (middle), and substrates (right).</p
<p>The chemical structures of the NSC666715 and its analogs NSC661073, NSC666713, NSC666717 and NSC6...
<p>The chemicals are numbered from #1 to #6 in order of the inhibition % calculated from FCCS analys...
<p>Chemical structures of bioactive α-GalCer derivatives and newly designed α-GalCer analogs.</p
<p>The chemical structure of four related compounds identified by virtual screening that were valida...
<p>Chemical structures of the docked compounds (A) Ligand_7 (B) Ligand_5 (C) ATP (D) Folic acid.</p
<p>Chemical structure of the drugs with TRPM8 antagonist activity used in this study.</p
<p>Molecular structures of NVS-PI3-2 (α inhibitor), HBC-417 (β inhibitor), NVS-PI3-3 (δ inhibitor) a...
<p>Chemical structure of the nicotinamide phosphoribosyltransferase inhibitor APO866.</p
<p>Chemical structure of screened inhibitors (A) ZINC01807204 (B) ZIC02318494.</p
<p>Chemical structures of the 6 hit compounds exhibiting anti-CHIKV activities.</p
<p>Chemical structures of the studied non-nucleoside reverse transcriptase inhibitors.</p
<p>Structures of compounds that are structurally related to the nine compounds identified in our vir...
<p>Chemical structures of fluorescein-di-β-d-galactopyranoside (FDG), fluorescein, and inhibitors.</...
<p>Molecular structures of the inhibitors: (A) PMI, (B) pDI, (C) WK23 and (D) WW8.</p
Chemical structures of Qi inhibitors (left), Qo inhibitors (middle), and substrates (right).</p
<p>The chemical structures of the NSC666715 and its analogs NSC661073, NSC666713, NSC666717 and NSC6...
<p>The chemicals are numbered from #1 to #6 in order of the inhibition % calculated from FCCS analys...
<p>Chemical structures of bioactive α-GalCer derivatives and newly designed α-GalCer analogs.</p
<p>The chemical structure of four related compounds identified by virtual screening that were valida...
<p>Chemical structures of the docked compounds (A) Ligand_7 (B) Ligand_5 (C) ATP (D) Folic acid.</p
<p>Chemical structure of the drugs with TRPM8 antagonist activity used in this study.</p
<p>Molecular structures of NVS-PI3-2 (α inhibitor), HBC-417 (β inhibitor), NVS-PI3-3 (δ inhibitor) a...
<p>Chemical structure of the nicotinamide phosphoribosyltransferase inhibitor APO866.</p